Alain Pralong on Sound Risk Management in Biomanufacturing

Contributor: Alain Pralong
Posted: 12/13/2013

Alain Pralong, VP New Product Introduction and Technical Life Cycle Management at GlaxoSmithKline Vaccines, speaks to Pharma IQ, about the challenges faced evaluating single-use systems for extractables and leachables and the need for sound risk management in biomanufacturing. Pralong also shares his opinion on the current regulatory landscape.

Pharma IQ: How much of a priority is extractable and leachable testing for you currently? And is it still one of the biggest issues that you have, when implementing single-use systems?

Contributor: Alain Pralong
Posted: 12/13/2013